News Center
With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.
01
2025
-
12
Exploring Linuo Pharmaceutical’s Smart Laboratory: Unlocking the Cutting-Edge Core Technologies Behind the “Quality Fortress” of Injectable Pharmaceuticals
Classification：
行业新闻
Corporate News
Remember last time when “Cloud Store Tour” took you to visit Lino Pharmaceutical’s Digital Intelligent No. 1 Factory? That lyophilized powder injection production line, capable of achieving a filling accuracy of ±1%, surely gave you a fresh perspective on intelligent pharmaceutical manufacturing, didn’t it?
Today, the second episode of Linuo Pharmaceutical’s “Store Tour” series continues its journey. This time, we’re turning our cameras toward the “quality gatekeeper” of Factory No. 1— the Smart Laboratory located on the second and third floors of the Quality Inspection and R&D Building. Covering a total area of 4,500 square meters, this laboratory is centered around the principles of “transparency, standardization, automation, informationization, and intelligence.” By combining cutting-edge instruments with intelligent equipment, it’s building an impenetrable safety barrier for every single vial of injectable medication. Now, let’s join us as we unveil its mysterious inner workings!
Transparency starts with space—data is authentic, and the process is controllable.
As soon as you step into the Smart Lab, the most immediate impression you’ll have is one of openness and transparency. The entire floor is divided by fully transparent glass partitions, making the experimental process crystal clear at a glance. This isn’t just for aesthetic purposes—it’s also a visual embodiment of the principle that “data must be authentic and processes must be controllable.”
Quick Overview of Highlight Areas—Not Just Instruments, But Precise Data Capturers!
The first thing that catches your eye is the liquid-phase room, where the high-performance liquid chromatograph and the ion chromatograph are neatly arranged. The high-performance liquid chromatograph is paired with a networked workstation, and instrument parameters are flashing in real time on the screen. “This ion chromatograph boasts an inspection sensitivity as low as the ppb level—meaning it can detect even trace amounts of impurities that would otherwise go unnoticed.”
A few steps ahead is the gas-phase chamber, where the gas chromatograph is currently running. The laboratory analyst explains: “It’s primarily responsible for determining the content of samples and detecting residual solvents, ensuring that every batch of products meets the release criteria.”
As we passed by the precision instrument room, we also caught sight of the “all-rounders in the detection field”—the gas chromatography-mass spectrometry (GC-MS) system, which can precisely detect trace contaminants. Even more impressive is the inductively coupled plasma mass spectrometry (ICP-MS) instrument, whose detection limit is as low as the ppt level (one part per trillion). It can accurately identify ultra-trace heavy metals such as lead and cadmium, making it truly deserving of the title “heavy-metal scanner” for injectables.
In the balance room, a millionth-of-a-gram balance is running quietly. The laboratory technician explains: “This balance achieves a weighing accuracy of 0.000001 grams—equivalent to one-thousandth the weight of a single human hair—meeting the ultra-trace weighing requirements in experiments and ensuring that the weights of pharmaceutical ingredients are measured with pinpoint precision.”
On the way, we stopped by Chuangxiang Space—a “humanistic little corner” within the lab. The tea-break area is adorned with greenery, offering employees a spot to take a brief respite and exchange ideas about experimental challenges. “Inspection work demands intense focus, but taking a moment to relax can actually make everyone more efficient. That’s precisely our original intention behind designing this lab: to combine cutting-edge technology with warmth and human touch.”
Black-tech Reserved Area—The Deep Integration of Technology and Intelligence in the Future
If the core testing area relies on “precision,” then the smart-device zone on the second floor is more like a “potential space” reserved for future intelligent upgrades—although the key equipment for this zone hasn’t yet been delivered, the dedicated rooms have already been meticulously planned and are ready to go. In the future, this area will become the central hub for laboratory automation and intelligence.
One of the rooms is reserved for an intelligent mobile phase preparation system. The room layout has been pre-planned according to the equipment’s requirements, and in the future, an intelligent mobile phase preparation system based on AI algorithms and visual inspection technology will be introduced here. According to the design plan, this system will subsequently integrate end-to-end modules—including solid powder feeding, precise liquid addition, real-time pH monitoring and automatic adjustment, vacuum filtration, and ultrasonic degassing—ultimately achieving fully automated mobile phase preparation.
Next door is a reserved space for the sample pretreatment system. According to the laboratory’s planning scheme, this system will in the future be able to autonomously perform the entire sequence of experimental operations, including precise weighing of powders, automatic addition of reagents, ultrasonic dissolution, volume calibration, oscillation and mixing, precise liquid transfer, centrifugal separation, and filtration and purification.
In addition to hardware reservations, the laboratory is also planning to build a “Digital Brain”—the upcoming LIMS system will serve as the key enabler for seamless integration of data across the entire process. According to the design, this system will subsequently cover the entire workflow, from sample reception and assignment of testing tasks to data collection and report generation. Meanwhile, the workshop will also introduce intelligent AGV sample-delivery robots as a complementary feature. At that time, samples from the workshop and warehouse will no longer require manual handling; instead, AGV robots will automatically deliver them to the laboratory. Moreover, testing data will be synchronized in real time to the interconnected decision-making platform at Digital Intelligence Plant No. 1, truly achieving data interoperability between “testing and production” and completely breaking down information silos.
As a high-standard, modern quality inspection platform, Linuo Pharmaceutical’s Smart Laboratory is committed to becoming a “technological fortress” driven by data-driven decision-making and enhanced by intelligent technologies. It eliminates doubts through transparency, solidifies its foundation with standardized practices, frees up human resources through automation, connects the dots via information technology, and anticipates the future with intelligence. In the future, this Smart Laboratory will collaborate closely with the production lines at Digital Intelligence Plant No. 1, forming a closed-loop system of “production—inspection—feedback.”
The Linuo Pharmaceutical Injection Project empowers manufacturing with intelligence and seeks resonance through openness. We look forward to exchanging ideas and learning from our upstream and downstream partners, fostering deep collaboration across R&D, production, and marketing, and jointly pursuing development for mutual benefit and win-win outcomes!
Related news
2026-05-18
On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating smart manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed high praise for the company’s practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.
2026-05-13
On May 13, the 92nd National Pharmaceutical Fair and the 94th China International API, Intermediate, Packaging & Equipment Exhibition (API China) opened in grand style at the Shanghai National Exhibition and Convention Center. As an innovative, publicly listed company in China’s chemical pharmaceutical sector, Shandong Keyuan Pharmaceutical Co., Ltd. (301281.SZ), together with its wholly owned subsidiary Shandong Linuo Pharmaceutical Co., Ltd., made a high‑profile appearance, showcasing a coordinated approach to APIs and finished dosage forms, a comprehensive end-to-end product portfolio, and strong brand synergy. The company highlighted its robust capabilities in innovative R&D, digital and intelligent manufacturing, green production, global supply chains, and clinical translation, while engaging domestic and international partners to explore emerging industry trends, expand new avenues of collaboration, and co‑create a thriving new ecosystem for the pharmaceutical and healthcare sectors.
2026-05-07
On May 6, Lino Pharmaceutical, a subsidiary of Keyuan Pharmaceutical (stock code: 301281.SZ), held a company-wide meeting in Jinan. Centered on the core principle of “unified strategy across the entire workforce and coordinated action across all business units,” the meeting comprehensively communicated the company’s development strategy and outlined the implementation roadmap, aligning the thinking and building consensus among all employees. With a spirit of concerted effort and synchronized momentum, the meeting charted a new blueprint for the company’s high-quality development.
2026-05-07
Recently, the Jinan Municipal Federation of Trade Unions officially announced the list of winners for the 2025 “Making Contributions in the Spring City” Innovation and Excellence Labor Competition. Shandong Linuo Pharmaceutical Co., Ltd.’s Solid Dosage Form Workshop stood out among numerous outstanding work teams across the city thanks to its remarkable performance, rigorous work style, and exceptional innovative capabilities, earning the prestigious First Prize for Work Teams.
ADD：#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China